Trinity Biotech’s Chief Technology Officer, Dr Gary Keating, added, “Our next phase of refinements, guided by this study’s positive results, will be tested in a second European pre-pivotal ...

Trinity Biotech reported a 3% increase in Q3 2024 revenue to $15.2 million, driven by strong demand for its TrinScreen HIV business. The company also highlighted significant growth in its Point-of ...

Trinity Biotech plc TRIB has announced the acquisition of privately held Irish deep-tech company Metabolomics Diagnostics. The acquired company specializes in the development of novel biomarker ...

Trinity Biotech plc (TRIB), a leading developer of diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market, has seen its stock price touch a 52-week low ...

DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

Commenting on the appointment, John Gillard, CEO of Trinity Biotech plc, said “We are delighted to welcome Louise, who brings extensive experience in transformation and growth within a dynamic ...

While Trinity Biotech plc (NASDAQ:TRIB) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. As a ...

Trinity Biotech sells direct in the United States, Germany, France, and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.

Trinity Biotech secures $4 million in debt financing to develop continuous glucose monitoring technology and enhance operational efficiency.

DUBLIN, Ireland, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Trinity Biotech plc shares dropped as much as 50% in premarket trade Tuesday after the company said it withdrew its device application with the Food and Drug Administration on the regulator's advice.